DANIsh VASculitis Database (DANIVAS)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorAarhus University Hospital
About this trial
The aim of this national pragmatic observational study is to investigate whether the use of new diagnostic imaging modalities facilitates disease stratification that can potentially predict treatment response, relapse risk and complications and hence guide management strategies to improve disease control and reduce disease and treatment related damage.
Eligibility criteria
Qualifiers
Are diagnosed with GCA or PMR within the last 5 years
Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
Speak and understand Danish
Are able to give signed and dated informed consent
Disqualifiers
Denies or are not able to give informed consent
Are diagnosed with other systemic autoimmune diseases that out-rules the diagnosis of GCA or PMR
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
2Led og Bindevævssygdomme, Aarhus University Hospital8200, Aarhus Denmark
Medicinsk klinik 2, Regionshospitalet Horsens8700, Horsens Denmark
Sponsors and collaborators
Aarhus University Hospital
Lead sponsor
Regionshospitalet Horsens
Collaborator
Aalborg University Hospital
Collaborator
Odense University Hospital
Collaborator
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborator
Holbaek Sygehus
Collaborator
Rigshospitalet, Denmark
Collaborator
Zealand University Hospital
Collaborator
Source ClinicalTrials.gov